Publication | Closed Access

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells

GliomaMedicineReceptor Tyrosine KinaseStem Cell ResearchCell DifferentiationCell BiologyTumor SuppressorStem CellsRadiation OncologyTumor MicroenvironmentLong-term ExposureGlioblastoma CellsHealth Sciences